# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mahatma Gandhi (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET009-SYN
- Date: 2026-07-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Arjun Malhotra, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Blood pressure, nutrition, vitamin B12 and D, and bone health review. **S**

## History of present illness

Mr. Gandhi returns about three months after refeeding. He reached full intake on the seventh day of refeeding and finished the supplements as planned. The repeat phosphate, potassium, and magnesium planned for three to four days after his last visit were not drawn; the order was placed but no appointment was booked. He has had no swelling, palpitations, or weakness. In June he had a near-fall from dehydration in hot weather; amlodipine was held for two days and restarted, and he now drinks more in the heat. His home blood pressure averages 126/74. He walks 5 km each morning again. His weight is back to 46.0 kg. He takes vitamin B12 and D daily and, with the dietitian, has added curd, dal, and a handful of groundnuts each day; his food record shows about 52 g of protein a day. **S**

| Element | Detail |
|---|---|
| Refeeding | Full intake by day 7; supplements completed |
| Missed check | Repeat electrolytes three to four days after the day 4 visit not drawn |
| Interval event | Near-fall from dehydration in June; amlodipine held two days |
| Home blood pressure | Average 126/74 mmHg on amlodipine 5 mg |
| Diet | Protein about 52 g a day; calcium from goat's milk and curd |
| Weight | 46.0 kg, back to his usual |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy back to usual; weight regained |
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Neurological | Negative | No dizziness on standing since June; no numbness or tingling |
| Musculoskeletal | Negative | No bone pain or falls |

4 systems reviewed. **S**

## Current medications

- Amlodipine 5 mg oral tablet, one tablet by mouth daily; hold on fast days and when standing blood pressure is below 110 systolic or he is dizzy on standing **S**
- Vitamin B12 (cyanocobalamin) 1 mg oral tablet, one tablet by mouth daily **S**
- Cholecalciferol (vitamin D3) 25 mcg (1000 units) oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/74 mmHg; pulse 64 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 46 kg; BMI 16.9 kg/m². All vital signs are synthetic.

Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Bicarbonate (total CO2): 25 mmol/L; BUN: 16 mg/dL; Creatinine: 0.83 mg/dL; eGFR: 94 mL/min/1.73 m²; Glucose: 84 mg/dL; Phosphate: 3.4 mg/dL; Magnesium: 2 mg/dL; Albumin: 4 g/dL; Vitamin B12: 452 pg/mL; Methylmalonic acid: 0.24 umol/L; Hemoglobin: 13.4 g/dL; MCV: 94 fL; 25-hydroxyvitamin D: 32 ng/mL; Mini Nutritional Assessment total score (0-30): 24. All results are synthetic.

## Change since baseline

- Sodium: 139 mmol/L at baseline, 139 mmol/L at this visit **S**
- Potassium: 4.1 mmol/L at baseline, 4.2 mmol/L at this visit **S**
- Bicarbonate (total CO2): 25 mmol/L at baseline, 25 mmol/L at this visit **S**
- BUN: 15 mg/dL at baseline, 16 mg/dL at this visit **S**
- Creatinine: 0.82 mg/dL at baseline, 0.83 mg/dL at this visit **S**
- eGFR: 94 mL/min/1.73 m² at baseline, 94 mL/min/1.73 m² at this visit **S**
- Glucose: 82 mg/dL at baseline, 84 mg/dL at this visit **S**
- Phosphate: 3.4 mg/dL at baseline, 3.4 mg/dL at this visit **S**
- Magnesium: 2 mg/dL at baseline, 2 mg/dL at this visit **S**
- Albumin: 3.9 g/dL at baseline, 4 g/dL at this visit **S**
- Vitamin B12: 238 pg/mL at baseline, 452 pg/mL at this visit **S**
- Methylmalonic acid: 0.48 umol/L (high) at baseline, 0.24 umol/L at this visit **S**
- Hemoglobin: 12.8 g/dL (low) at baseline, 13.4 g/dL at this visit **S**
- MCV: 99 fL at baseline, 94 fL at this visit **S**
- 25-hydroxyvitamin D: 19 ng/mL (low) at baseline, 32 ng/mL at this visit **S**
- Mini Nutritional Assessment total score (0-30): 20 at baseline, 24 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Thin and well; BMI 16.9 |
| Orthostatic vital signs | Lying 130/76, standing at three minutes 124/72; no symptoms |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Mouth | Tongue normal |
| Neurological | Vibration sense normal at the toes |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hypertension** (I10). Office 128/74 and home 126/74 mmHg, below 130/80, with no drop on standing. Creatinine 0.83 mg/dL (eGFR 94) and potassium 4.2 mmol/L; the June rise has resolved. **S**
   - Continue amlodipine 5 mg with the hold rules.
   - Extra fluids in hot weather.
2. **Vitamin B12 deficiency** (E53.8). Repleted: B12 452 pg/mL, methylmalonic acid 0.24 umol/L, hemoglobin 13.4 g/dL, MCV 94 fL. **S**
   - Continue vitamin B12 1 mg daily long term, since his diet supplies little.
3. **Vitamin D deficiency** (E55.9). 25-hydroxyvitamin D 32 ng/mL. **S**
   - Continue 1000 units daily.
4. **Underweight** (R63.6). Weight 46.0 kg; Mini Nutritional Assessment 24, now in the normal range; albumin 4.0 g/dL. **S**
   - Keep protein at 1.0 to 1.2 g/kg a day.
   - Before any future fast, repeat the fast safety plan and refeeding protocol.
5. **Refeeding hypophosphatemia** (E83.39). Resolved: phosphate 3.4 mg/dL and magnesium 2.0 mg/dL. **S**
   - No further supplements.
6. **Low bone mass** (M85.80). Calcium intake about 1000 mg a day from food; vitamin D replete. **S**
   - Repeat DXA in two years.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure | Every visit | Completed today | 128/74 mmHg |
| Self-management | Home blood pressure monitoring | After treatment changes | Completed today | Average 126/74 mmHg |
| Examination | Orthostatic blood pressure | Every visit | Completed today | No drop on standing |
| Examination | Weight and BMI | Every visit | Completed today | 46.0 kg, BMI 16.9 |
| Laboratory | Metabolic panel | Yearly on a calcium channel blocker; recheck after the June rise in creatinine | Completed today | Sodium 139, potassium 4.2 mmol/L, bicarbonate 25; BUN 16, creatinine 0.83 mg/dL, eGFR 94; glucose 84 mg/dL |
| Laboratory | Repeat phosphate, potassium, and magnesium 3 to 4 days after the day 4 result | Until stable during refeeding | Deferred | Not drawn, a deviation from the protocol: the order was placed but no appointment booked. No harm on today's evidence: no symptoms were reported on the daily calls, he reached full intake on day 7, and phosphate is 3.4 and magnesium 2.0 mg/dL today. Corrective action: the same appointment-booking rule as after the day 2 and 3 misses, now applied to every refeeding recheck |
| Laboratory | Vitamin B12, methylmalonic acid, and blood count after replacement | Three to four months after starting | Completed today | B12 452 pg/mL, methylmalonic acid 0.24 umol/L, hemoglobin 13.4 g/dL, MCV 94 fL |
| Laboratory | 25-hydroxyvitamin D after repletion | After repletion, then yearly | Completed today | 32 ng/mL |
| Survey | Mini Nutritional Assessment and albumin | At follow-up of a person at nutritional risk | Completed today | MNA 24 (normal); albumin 4.0 g/dL |
| Self-management | Protein and calcium intake | Every visit with the dietitian | Completed today | About 52 g of protein and 1000 mg of calcium a day |
| Imaging | DXA | Every 2 years | Up to date | Done in March; next due in two years |
| Examination | Fundoscopic examination | Yearly in chronic hypertension | Due | Not yet done; to be booked at the wellness visit, within the yearly window |
| Laboratory | Lipids, urine albumin-creatinine ratio, and HbA1c | Yearly | Up to date | Normal in February |
| Survey | PHQ-9 and cardiovascular risk estimate | Yearly | Up to date | Done in February; statin decision to be revisited at the wellness visit |
| Self-management | Falls prevention | Ongoing | Completed today | No falls; one near-fall in June; fluids in heat and slow standing |

## Goal progress

- Office and home blood pressure below 130/80 without dizziness on standing. Outcome by 2026-07-13: 128/74 mmHg on amlodipine 5 mg, with no drop on standing. **S**
- Complete the fast and refeeding without a refeeding complication that needs hospital care. Outcome by 2026-04-16: No hospital care; mild hypophosphatemia on day 4 treated by mouth. **S**
- Weight back to at least 46 kg after the fast. Outcome by 2026-07-13: 46.0 kg. **S**
- Normal vitamin B12 status and vitamin D of at least 30 ng/mL. Outcome by 2026-07-13: Methylmalonic acid 0.24 umol/L; vitamin D 32 ng/mL. **S**
- Protein of about 1.0 to 1.2 g/kg a day (about 50 to 55 g) from foods he eats. Outcome by 2026-07-13: About 52 g a day by his food record; working toward the upper end. **S**
- No falls. Outcome by 2026-07-13: No falls; one near-fall from low blood pressure in hot weather in June. **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (J Am Coll Cardiol 2025;86(18):1567-1678)
- Indian guidelines on hypertension-IV (2019) (2019), Association of Physicians of India and partner societies (J Hum Hypertens 2020;34(11):745-758)
- Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition (CG32) (2006, updated 2017), National Institute for Health and Care Excellence
- ASPEN Consensus Recommendations for Refeeding Syndrome (2020), American Society for Parenteral and Enteral Nutrition (Nutr Clin Pract 2020;35(2):178-195)
- The clinician's guide to prevention and treatment of osteoporosis (2022), Bone Health and Osteoporosis Foundation (Osteoporos Int 2022;33(10):2049-2102)
- Falls Prevention in Community-Dwelling Older Adults: Interventions (2024), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, hypertension and osteoporosis monographs (2026), Aether Forge

## Follow-up

- Annual wellness visit in September. Blood pressure review in three months. **S**
- Next scheduled visit 2026-09-14: subsequent annual wellness visit. **S**
